ToxSci Advance Access originally published online on August 13, 2007
Toxicological Sciences 2008 101(2):186-196; doi:10.1093/toxsci/kfm214
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Xenobiotic Transporters: Ascribing Function from Gene Knockout and Mutation Studies
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, 3901 Rainbow Building, Kansas City, Kansas 66160-7417
1 To whom correspondence should be addressed. Fax: (913) 588-7501. E-mail: cklaasse{at}kumc.edu.
Received June 18, 2007; accepted August 8, 2007
 |
Abstract |
|---|
Transporter-mediated absorption, secretion, and reabsorption of chemicals are increasingly recognized as important determinants in the biological activities of many xenobiotics. In recent years, the rapid progress in generating and characterizing mice with targeted deletion of transporters has greatly increased our knowledge of the functions of transporters in the pharmacokinetics/toxicokinetics of xenobiotics. In this introduction, we focus on functions of transporters learned from experiments on knockout mice as well as humans and rodents with natural mutations of these transporters. We limit our discussion to transporters that either directly transport xenobiotics or are important in biliary excretion or cellular defenses, namely multidrug resistance, multidrug resistance–associated proteins, breast cancer resistance protein, organic anion transporting polypeptides, organic anion transporters, organic cation transporters, nucleoside transporters, peptide transporters, bile acid transporters, cholesterol transporters, and phospholipid transporters, as well as metal transporters. Efflux transporters in intestine, liver, kidney, brain, testes, and placenta can efflux xenobiotics out of cells and serve as barriers against the entrance of xenobiotics into cells, whereas many xenobiotics enter the biological system via uptake transporters. The functional importance of a given transporter in each tissue depends on its substrate specificity, expression level, and the presence/absence of other transporters with overlapping substrate preferences. Nevertheless, a transporter may affect a tissue independent of its local expression by altering systemic metabolism. Further studies on the gene regulation and function of transporters, as well as the interrelationship between transporters and phase I/II xenobiotic-metabolizing enzymes, will provide a complete framework for developing novel strategies to protect us from xenobiotic insults.
Key Words: transporter; function; xenobiotics; knockout; mice.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. L. Csanaky, L. M. Aleksunes, Y. Tanaka, and C. D. Klaassen Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice Am J Physiol Gastrointest Liver Physiol, September 1, 2009; 297(3): G419 - G433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Reisman, I. L. Csanaky, L. M. Aleksunes, and C. D. Klaassen Altered Disposition of Acetaminophen in Nrf2-null and Keap1-knockdown Mice Toxicol. Sci., May 1, 2009; 109(1): 31 - 40. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lecureux, M. Z. Dieter, D. M. Nelson, L. Watson, H. Wong, B. Gemzik, C. D. Klaassen, and L. D. Lehman-McKeeman Hepatobiliary Disposition of Thyroid Hormone in Mrp2-Deficient TR- Rats: Reduced Biliary Excretion of Thyroxine Glucuronide Does Not Prevent Xenobiotic-Induced Hypothyroidism Toxicol. Sci., April 1, 2009; 108(2): 482 - 491. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Reisman, R. L. Yeager, M. Yamamoto, and C. D. Klaassen Increased Nrf2 Activation in Livers from Keap1-Knockdown Mice Increases Expression of Cytoprotective Genes that Detoxify Electrophiles more than those that Detoxify Reactive Oxygen Species Toxicol. Sci., March 1, 2009; 108(1): 35 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. W. Kim, H. E. Kang, M. G. Lee, S. J. Hwang, S. C. Kim, C. H. Lee, and S. G. Kim Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G372 - G381. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-K. J. Zhang, R. L. Yeager, and C. D. Klaassen Circadian Expression Profiles of Drug-Processing Genes and Transcription Factors in Mouse Liver Drug Metab. Dispos., January 1, 2009; 37(1): 106 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Lee, W. O. Ward, D. C. Wolf, J. W. Allen, C. Mills, M. J. DeVito, and J. C. Corton Coordinated Changes in Xenobiotic Metabolizing Enzyme Gene Expression in Aging Male Rats Toxicol. Sci., November 1, 2008; 106(1): 263 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Evers and X.-Y. Chu Role of the Murine Organic Anion-Transporting Polypeptide 1b2 (Oatp1b2) in Drug Disposition and Hepatotoxicity Mol. Pharmacol., August 1, 2008; 74(2): 309 - 311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Lehman-McKeeman Beam Me Up Scotty: Incorporating Transporters in Physiologically Based Pharmacokinetic-Pharmacodynamic Modeling Toxicol. Sci., July 1, 2008; 104(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
H. Lu, S. Choudhuri, K. Ogura, I. L. Csanaky, X. Lei, X. Cheng, P.-z. Song, and C. D. Klaassen Characterization of Organic Anion Transporting Polypeptide 1b2-null Mice: Essential Role in Hepatic Uptake/Toxicity of Phalloidin and Microcystin-LR Toxicol. Sci., May 1, 2008; 103(1): 35 - 45. [Abstract] [Full Text] [PDF]
|
|